Vistagen Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VTGN | 18H0.F | SILO | IBO | PULM | DARE | |
|---|---|---|---|---|---|---|
| Market cap | 8.18M | 5.11M | 2.93M | 35.42M | 5.55M | 13.02M |
| P/E (TTM) | — | — | — | 0.4 | — | — |
| Forward P/E | -0.1 | — | -1.9 | — | -0.3 | -1.3 |
| Price/book | 0.3 | -1.1 | 0.3 | 3.3 | 3.5 | -17.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −95.52% | −25.00% | −82.01% | −39.34% | −68.19% | −63.43% |
| Today | +9.70% | −23.81% | +3.91% | +1.99% | +14.29% | +1.83% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All VTGN news ›Madrigal Pharmaceuticals (NASDAQ:MDGL) vs. VistaGen Therapeutics (NASDAQ:VTGN) Critical Survey
Posted by Danessa Lincoln on Nov 1st, 2026 Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) and VistaGen Therapeutics (NASDAQ:VTGN – Get Free Report) are both healthcare companies, but which is the superior business? We will…
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Stock Has Consensus Target Price of $0.95
Posted by Sarita Garza on Oct 13th, 2026 Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of VistaGen Therapeutics in a report on Monday, August 31st. Check Out Our Latest Stock Analysis on VTGN VistaGen Therapeutics,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.